Fructose and hepatic insulin resistance

References

• Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10(11):686–690.
   PubMed Web of Science ®Google Scholar
• Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118(4):1388–1393.
   PubMed Web of Science ®Google Scholar
• Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148(3):547–555.
   PubMed Web of Science ®Google Scholar
• Softic S, Kahn CR. Fatty liver disease: is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease? Eur J Gastroenterol Hepatol. 2019;31(1):143.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50(8):1844–1850.
   PubMed Web of Science ®Google Scholar
• Softic S, Cohen DE, Kahn CR. Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease. Dig Dis Sci. 2016;61(5):1282–1293.
   PubMed Web of Science ®Google Scholar
• Jensen T, Abdelmalek MF, Sullivan S, et al. Fructose and sugar: a major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018;68(5):1063–1075.
   PubMed Web of Science ®Google Scholar
• Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119(5):1322–1334.
   PubMed Web of Science ®Google Scholar
• Bazzano LA, Li TY, Joshipura KJ, et al. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care. 2008;31(7):1311–1317.
   PubMed Web of Science ®Google Scholar
• Softic S, Gupta MK, Wang GX, et al. Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. J Clin Invest. 2017;127(11):4059–4074.
   PubMed Web of Science ®Google Scholar
• Beck-Nielsen H, Pedersen O, Lindskov HO. Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects. Am J Clin Nutr. 1980;33(2):273–278.
   PubMed Web of Science ®Google Scholar
• Beck-Nielsen H, Pedersen O, Schwartz Sørensen N. Effects of diet on the cellular insulin binding and the insulin sensitivity in young normals. Diabetolgia. 1978;15(4):289–296.
   PubMed Web of Science ®Google Scholar
• Faeh D, Minehira K, Schwarz J-M, et al. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes. 2005;54(7):1907–1913.
   PubMed Web of Science ®Google Scholar
• Le KA, Ith M, Kreis R, et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr. 2009;89(6):1760–1765.
   PubMed Web of Science ®Google Scholar
• Lecoultre V, Carrel G, Egli L, et al. Coffee consumption attenuates short-term fructose-induced liver insulin resistance in healthy men. Am J Clin Nutr. 2014;99(2):268–275.
   PubMed Web of Science ®Google Scholar
• Johnston RD, Stephenson MC, Crossland H, et al. No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. Gastroenterology. 2013;145(5):1016–1025 e2.
   PubMed Web of Science ®Google Scholar
• Taskinen MR, Soderlund S, Bogl LH, et al. Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity. J Intern Med. 2017;282(2):187–201.
   PubMed Web of Science ®Google Scholar
• Aeberli I, Hochuli M, Gerber PA, et al. Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial. Diabetes Care. 2013;36(1):150–156.
   PubMed Web of Science ®Google Scholar
• Schwarz JM, Noworolski SM, Wen MJ, et al. Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat. J Clin Endocrinol Metab. 2015;100(6):2434–2442.
   PubMed Web of Science ®Google Scholar
• Hallfrisch J, Ellwood KC, Michaelis OE, et al. Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men. J Nutr. 1983;113(9):1819–1826.
   PubMed Web of Science ®Google Scholar
• Wu T, Giovannucci E, Pischon T, et al. Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in US women. Am J Clin Nutr. 2004;80(4):1043–1049.
   PubMed Web of Science ®Google Scholar
• Imamura F, O'Connor L, Ye Z, et al. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. Br J Sports Med. 2016;50(8):496–504.
   PubMed Web of Science ®Google Scholar
• Ter Horst KW, Schene MR, Holman R, et al. Effect of fructose consumption on insulin sensitivity in nondiabetic subjects: a systematic review and meta-analysis of diet-intervention trials. Am J Clin Nutr. 2016;104(6):1562–1576.
   PubMed Web of Science ®Google Scholar
• Samuel VT. Fructose induced lipogenesis: from sugar to fat to insulin resistance. Trends Endocrinol Metab. 2011;22(2):60–65.
   PubMed Web of Science ®Google Scholar
• Kennedy AR, Pissios P, Otu H, et al. A high-fat, ketogenic diet induces a unique metabolic state in mice. Am J Physiol Endocrinol Metab. 2007;292(6):E1724–39.
   PubMed Web of Science ®Google Scholar
• Hellerstein MK, Schwarz JM, Neese RA. Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr. 1996;16(1):523–557.
   PubMedGoogle Scholar
• Lecoultre V, Egli L, Carrel G, et al. Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans. Obesity. 2013;21(4):782–785.
   PubMed Web of Science ®Google Scholar
• Parks EJ, Skokan LE, Timlin MT, et al. Dietary sugars stimulate fatty acid synthesis in adults. J Nutr. 2008;138(6):1039–1046.
   PubMed Web of Science ®Google Scholar
• Softic S, Kirby M, Berger NG, et al. Insulin concentration modulates hepatic lipid accumulation in mice in part via transcriptional regulation of fatty acid transport proteins. PLoS One. 2012;7(6):e38952.
   PubMed Web of Science ®Google Scholar
• Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109(9):1125–1131.
   PubMed Web of Science ®Google Scholar
• Chong MF, Fielding BA, Frayn KN. Mechanisms for the acute effect of fructose on postprandial lipemia. Am J Clin Nutr. 2007;85(6):1511–1520.
   PubMed Web of Science ®Google Scholar
• Haas JT, Miao J, Chanda D, et al. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. Cell Metab. 2012;15(6):873–884.
   PubMed Web of Science ®Google Scholar
• Nagai Y, Yonemitsu S, Erion DM, et al. The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Cell Metab. 2009;9(3):252–264.
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Dobrzyn A, Man WC, et al. Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. J Biol Chem. 2004;279(24):25164–25171.
   PubMed Web of Science ®Google Scholar
• Lanaspa MA, Sanchez-Lozada LG, Cicerchi C, et al. Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver. PLoS One. 2012;7(10):e47948.
   PubMed Web of Science ®Google Scholar
• Kim MS, Krawczyk SA, Doridot L, et al. ChREBP regulates fructose-induced glucose production independently of insulin signaling. J Clin Invest. 2016;126(11):4372–4386.
   PubMed Web of Science ®Google Scholar
• Ma L, Robinson LN, Towle HC. ChREBP*Mlx is the principal mediator of glucose-induced gene expression in the liver. J Biol Chem. 2006;281(39):28721–28730.
   PubMed Web of Science ®Google Scholar
• Dentin R, Benhamed F, Hainault I, et al. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes. 2006;55(8):2159–2170.
   PubMed Web of Science ®Google Scholar
• Iizuka K, Bruick RK, Liang G, et al. Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci U S A. 2004;101(19):7281–7286.
   PubMed Web of Science ®Google Scholar
• Zhang D, Tong X, VanDommelen K, et al. Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity. J Clin Invest. 2017;127(7):2855–2867.
   PubMed Web of Science ®Google Scholar
• Benhamed F, Denechaud PD, Lemoine M, et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest. 2012;122(6):2176–2194.
   PubMed Web of Science ®Google Scholar
• Marmier S, Dentin R, Daujat-Chavanieu M, et al. Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking. Hepatology. 2015;62(4):1086–1100.
   PubMed Web of Science ®Google Scholar
• Tornheim K, Lowenstein JM. Control of phosphofructokinase from rat skeletal muscle. Effects of fructose diphosphate, AMP, ATP, and citrate. J Biol Chem. 1976;251(23):7322–7328.
   PubMed Web of Science ®Google Scholar
• Puri P, Baillie RA, Wiest MM, et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology. 2007;46(4):1081–1090.
   PubMed Web of Science ®Google Scholar
• Kovacs P, Stumvoll M. Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab. 2005;19(4):625–635.
   PubMed Web of Science ®Google Scholar
• Boden G, She P, Mozzoli M, et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-kappaB pathway in rat liver. Diabetes. 2005;54(12):3458–3465.
   PubMed Web of Science ®Google Scholar
• Lewis GF, Carpentier A, Adeli K, et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev. 2002;23(2):201–229.
   PubMed Web of Science ®Google Scholar
• Perry RJ, Camporez JG, Kursawe R, et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015;160(4):745–758.
   PubMed Web of Science ®Google Scholar
• Bevilacqua S, Bonadonna R, Buzzigoli G, et al. Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. Metabolism. 1987;36(5):502–506.
   PubMed Web of Science ®Google Scholar
• Chan SM, Sun RQ, Zeng XY, et al. Activation of PPARalpha ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes. 2013;62(6):2095–2105.
   PubMed Web of Science ®Google Scholar
• Nomura K, Yamanouchi T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem. 2012;23(3):203–208.
   PubMed Web of Science ®Google Scholar
• Jurczak MJ, Lee AH, Jornayvaz FR, et al. Dissociation of inositol-requiring enzyme (IRE1alpha)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice. J Biol Chem. 2012;287(4):2558–2567.
   PubMed Web of Science ®Google Scholar
• Kopf T, Schaefer HL, Troetzmueller M, et al. Influence of fenofibrate treatment on triacylglycerides, diacylglycerides and fatty acids in fructose fed rats. PLoS One. 2014;9(9):e106849.
   PubMed Web of Science ®Google Scholar
• Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010;375(9733):2267–2277.
   PubMed Web of Science ®Google Scholar
• Vila L, Roglans N, Alegret M, et al. Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism. Hepatology. 2008;48(5):1506–1516.
   PubMed Web of Science ®Google Scholar
• Crescenzo R, Mazzoli A, Di Luccia B, et al. Dietary fructose causes defective insulin signalling and ceramide accumulation in the liver that can be reversed by gut microbiota modulation. Food Nutr Res. 2017;61(1):1331657.
   PubMed Web of Science ®Google Scholar
• Softic S, Meyer JG, Wang GX, et al. Dietary sugars alter hepatic fatty acid oxidation via transcriptional and post-translational modifications of mitochondrial proteins. Cell Metab. 2019;30(4):735–753 e4.
   PubMed Web of Science ®Google Scholar
• Liu L, Zhang Y, Chen N, et al. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest. 2007;117(6):1679–1689.
   PubMed Web of Science ®Google Scholar
• Cox CL, Stanhope KL, Schwarz JM, et al. Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks. J Clin Endocrinol Metab. 2011;96(12):E2034–8.
   PubMed Web of Science ®Google Scholar
• Lanaspa MA, Cicerchi C, Garcia G, et al. Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver. PLoS One. 2012;7(11):e48801.
   PubMed Web of Science ®Google Scholar
• Rawat AK, Menahan LA. Antiketogenic action of fructose, glyceraldehyde, and sorbitol in the rat in vivo. Diabetes. 1975;24(10):926–932.
   PubMed Web of Science ®Google Scholar
• Ter Horst KW, Serlie MJ. Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease. Nutrients. 2017;9(9):981.
   Web of Science ®Google Scholar
• Topping DL, Mayes PA. The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism. Biochem J. 1972;126(2):295–311.
   PubMed Web of Science ®Google Scholar
• Prager GN, Ontko JA. Direct effects of fructose metabolism on fatty acid oxidation in a recombined rat liver mitochondria-hish speed supernatant system. Biochim Biophys Acta. 1976;424(3):386–395.
   PubMedGoogle Scholar
• Su Q, Baker C, Christian P, et al. Hepatic mitochondrial and ER stress induced by defective PPARalpha signaling in the pathogenesis of hepatic steatosis. Am J Physiol Endocrinol Metab. 2014;306(11):E1264–73.
   PubMed Web of Science ®Google Scholar
• Ohashi K, Munetsuna E, Yamada H, et al. High fructose consumption induces DNA methylation at PPARalpha and CPT1A promoter regions in the rat liver. Biochem Biophys Res Commun. 2015;468(1–2):185–189.
   PubMed Web of Science ®Google Scholar
• Iizuka K, Wu W, Horikawa Y, et al. Feedback looping between ChREBP and PPARalpha in the regulation of lipid metabolism in brown adipose tissues. Endocr J. 2013;60(10):1145–1153.
   PubMed Web of Science ®Google Scholar
• Boergesen M, Poulsen L, Schmidt SF, et al. ChREBP mediates glucose repression of peroxisome proliferator-activated receptor alpha expression in pancreatic beta-cells. J Biol Chem. 2011;286(15):13214–13225.
   PubMed Web of Science ®Google Scholar
• Nakagawa T, Hu H, Zharikov S, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006;290(3):F625–31.
   PubMed Web of Science ®Google Scholar
• Asipu A, Hayward BE, O'Reilly J, et al. Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria. Diabetes. 2003;52(9):2426–2432.
   PubMed Web of Science ®Google Scholar
• Boesiger P, Buchli R, Meier D, et al. Changes of liver metabolite concentrations in adults with disorders of fructose metabolism after intravenous fructose by 31P magnetic resonance spectroscopy. Pediatr Res. 1994;36(4):436–440.
   PubMed Web of Science ®Google Scholar
• Cannon JR, Harvison PJ, Rush GF. The effects of fructose on adenosine triphosphate depletion following mitochondrial dysfunction and lethal cell injury in isolated rat hepatocytes. Toxicol Appl Pharmacol. 1991;108(3):407–416.
   PubMed Web of Science ®Google Scholar
• Abdelmalek MF, Lazo M, Horska A, et al. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology. 2012;56(3):952–960.
   PubMed Web of Science ®Google Scholar
• Maenpaa PH, Raivio KO, Kekomaki MP. Liver adenine nucleotides: fructose-induced depletion and its effect on protein synthesis. Science. 1968;161(3847):1253–1254.
   PubMed Web of Science ®Google Scholar
• Lanaspa MA, Sanchez-Lozada LG, Choi YJ, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287(48):40732–40744.
   PubMed Web of Science ®Google Scholar
• Cicerchi C, Li N, Kratzer J, et al. Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids. Faseb J. 2014;28(8):3339–3350.
   PubMed Web of Science ®Google Scholar
• Sanchez-Lozada LG, Andres-Hernando A, Garcia-Arroyo FE, et al. Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats. J Biol Chem. 2019;294(11):4272–4281.
   PubMed Web of Science ®Google Scholar
• Ives A, Nomura J, Martinon F, et al. Xanthine oxidoreductase regulates macrophage IL1beta secretion upon NLRP3 inflammasome activation. Nat Commun. 2015;6(1):6555.
   PubMedGoogle Scholar
• Wan X, Xu C, Lin Y, et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64(4):925–932.
   PubMed Web of Science ®Google Scholar
• Choi WG, Han J, Kim JH, et al. eIF2alpha phosphorylation is required to prevent hepatocyte death and liver fibrosis in mice challenged with a high fructose diet. Nutr Metab (Lond). 2017;14:48.
   PubMed Web of Science ®Google Scholar
• Bagul PK, Middela H, Matapally S, et al. Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats. Pharmacol Res. 2012;66(3):260–268.
   PubMed Web of Science ®Google Scholar
• Cioffi F, Senese R, Lasala P, et al. Fructose-rich diet affects mitochondrial DNA damage and repair in rats. Nutrients. 2017;9(4):323.
   Web of Science ®Google Scholar
• Ren LP, Chan SM, Zeng XY, et al. Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance. PLoS One. 2012;7(2):e30816.
   PubMed Web of Science ®Google Scholar
• Bhuvaneswari S, Yogalakshmi B, Sreeja S, et al. Astaxanthin reduces hepatic endoplasmic reticulum stress and nuclear factor-kappaB-mediated inflammation in high fructose and high fat diet-fed mice. Cell Stress Chaperones. 2014;19(2):183–191.
   PubMed Web of Science ®Google Scholar
• Sun RQ, Wang H, Zeng XY, et al. IRE1 impairs insulin signaling transduction of fructose-fed mice via JNK independent of excess lipid. Biochim Biophys Acta. 2015;1852(1):156–165.
   PubMed Web of Science ®Google Scholar
• Lee AH, Scapa EF, Cohen DE, et al. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science. 2008;320(5882):1492–1496.
   PubMed Web of Science ®Google Scholar
• Zhang C, Chen X, Zhu RM, et al. Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice. Toxicol Lett. 2012;212(3):229–240.
   PubMed Web of Science ®Google Scholar
• Ge CX, Yu R, Xu MX, et al. Betaine prevented fructose-induced NAFLD by regulating LXRalpha/PPARalpha pathway and alleviating ER stress in rats. Eur J Pharmacol. 2016;770:154–164.
   PubMed Web of Science ®Google Scholar
• Kornmann B, Currie E, Collins SR, et al. An ER-mitochondria tethering complex revealed by a synthetic biology screen. Science. 2009;325(5939):477–481.
   PubMed Web of Science ®Google Scholar
• Breckenridge DG, Stojanovic M, Marcellus RC, et al. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol. 2003;160(7):1115–1127.
   PubMed Web of Science ®Google Scholar
• Wang H, Sun RQ, Zeng XY, et al. Restoration of autophagy alleviates hepatic ER stress and impaired insulin signalling transduction in high fructose-fed male mice. Endocrinology. 2015;156(1):169–181.
   PubMed Web of Science ®Google Scholar
• Kohli R, Kirby M, Xanthakos SA, et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology. 2010;52(3):934–944.
   PubMed Web of Science ®Google Scholar
• Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014;6(1):a009191.
   PubMed Web of Science ®Google Scholar
• Wei Y, Pagliassotti MJ. Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance. Am J Physiol Endocrinol Metab. 2004;287(5):E926–33.
   PubMed Web of Science ®Google Scholar
• Wei Y, Wang D, Pagliassotti MJ. Fructose selectively modulates c-jun N-terminal kinase activity and insulin signaling in rat primary hepatocytes. J Nutr. 2005;135(7):1642–1646.
   PubMed Web of Science ®Google Scholar
• Kelley GL, Allan G, Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology. 2004;145(2):548–555.
   PubMed Web of Science ®Google Scholar
• Collino M, Aragno M, Castiglia S, et al. Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. Br J Pharmacol. 2010;160(8):1892–1902.
   PubMed Web of Science ®Google Scholar
• Softic S, Boucher J, Solheim MH, et al. Lipodystrophy due to adipose tissue-specific insulin receptor knockout results in progressive NAFLD. Diabetes. 2016;65(8):2187–2200.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang JH, Chen XY, et al. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation. Antioxid Redox Signal. 2015;22(10):848–870.
   PubMed Web of Science ®Google Scholar
• Jaiswal N, Agrawal S, Agrawal A. High fructose-induced metabolic changes enhance inflammation in human dendritic cells. Clin Exp Immunol. 2019;197(2):237–249.
   PubMed Web of Science ®Google Scholar
• Ghoreschi K, Laurence A, Yang XP, et al. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature. 2010;467(7318):967–971.
   PubMed Web of Science ®Google Scholar
• El-Behi M, Ciric B, Dai H, et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol. 2011;12(6):568–575.
   PubMed Web of Science ®Google Scholar
• Harley IT, Stankiewicz TE, Giles DA, et al. IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice. Hepatology. 2014;59(5):1830–1839.
   PubMed Web of Science ®Google Scholar
• Mukherjee R, Moreno-Fernandez ME, Giles DA, et al. Nicotinamide adenine dinucleotide phosphate (reduced) oxidase 2 modulates inflammatory vigor during nonalcoholic fatty liver disease progression in mice. Hepatol Commun. 2018;2(5):546–560.
   PubMed Web of Science ®Google Scholar
• Moreno-Fernandez ME, Giles DA, Stankiewicz TE, et al. Peroxisomal beta-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease. JCI Insight. 2018;3(6):93626.
   PubMed Web of Science ®Google Scholar
• Giles DA, Moreno-Fernandez ME, Divanovic S. IL-17 axis driven inflammation in non-alcoholic fatty liver disease progression. Curr Drug Targets. 2015;16(12):1315–1323.
   PubMed Web of Science ®Google Scholar
• Giles DA, Moreno-Fernandez ME, Stankiewicz TE, et al. Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling. Nat Med. 2017;23(7):829–838.
   PubMed Web of Science ®Google Scholar
• Giles DA, Ramkhelawon B, Donelan EM, et al. Modulation of ambient temperature promotes inflammation and initiates atherosclerosis in wild type C57BL/6 mice. Mol Metab. 2016;5(11):1121–1130.
   PubMed Web of Science ®Google Scholar
• Tian XY, Ganeshan K, Hong C, et al. Thermoneutral housing accelerates metabolic inflammation to potentiate atherosclerosis but not insulin resistance. Cell Metab. 2016;23(1):165–178.
   PubMed Web of Science ®Google Scholar
• Catena C, Giacchetti G, Novello M, et al. Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension. Am J Hypertens. 2003;16(11):973–978.
   PubMed Web of Science ®Google Scholar
• Vila L, Roglans N, Perna V, et al. Liver AMP/ATP ratio and fructokinase expression are related to gender differences in AMPK activity and glucose intolerance in rats ingesting liquid fructose. J Nutr Biochem. 2011;22(8):741–751.
   PubMed Web of Science ®Google Scholar
• Honma M, Sawada S, Ueno Y, et al. Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers. Int J Obes. 2018;42(9):1544–1555.
   Web of Science ®Google Scholar
• Shimomura I, Matsuda M, Hammer RE, et al. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell. 2000;6(1):77–86.
   PubMed Web of Science ®Google Scholar
• Rebollo A, Roglans N, Baena M, et al. Liquid fructose down-regulates liver insulin receptor substrate 2 and gluconeogenic enzymes by modifying nutrient sensing factors in rats. J Nutr Biochem. 2014;25(2):250–258.
   PubMed Web of Science ®Google Scholar
• Baena M, Sanguesa G, Davalos A, et al. Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues. Sci Rep. 2016;6(1):26149.
   PubMed Web of Science ®Google Scholar
• Gum RJ, Gaede LL, Koterski SL, et al. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes. 2003;52(1):21–28.
   PubMed Web of Science ®Google Scholar
• Zinker BA, Rondinone CM, Trevillyan JM, et al. PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci USA. 2002;99(17):11357–11362.
   PubMed Web of Science ®Google Scholar
• Tamrakar AK, Maurya CK, Rai AK. PTP1B inhibitors for type 2 diabetes treatment: a patent review (2011–2014). Expert Opin Ther Pat. 2014;24(10):1101–1115.
   PubMed Web of Science ®Google Scholar
• Taghibiglou C, Rashid-Kolvear F, Van Iderstine SC, et al. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem. 2002;277(1):793–803.
   PubMed Web of Science ®Google Scholar
• Bezerra RM, Ueno M, Silva MS, et al. A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J Nutr. 2000;130(6):1531–1535.
   PubMed Web of Science ®Google Scholar
• Ueno M, Bezerra RM, Silva MS, et al. A high-fructose diet induces changes in pp185 phosphorylation in muscle and liver of rats. Braz J Med Biol Res. 2000;33(12):1421–1427.
   PubMed Web of Science ®Google Scholar
• Li JM, Li YC, Kong LD, et al. Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats. Hepatology. 2010;51(5):1555–1566.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Ugi S, Maegawa H, et al. Protein-tyrosine phosphatase 1B as new activator for hepatic lipogenesis via sterol regulatory element-binding protein-1 gene expression. J Biol Chem. 2003;278(44):43095–43101.
   PubMed Web of Science ®Google Scholar
• Ishimoto T, Lanaspa MA, Rivard CJ, et al. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology. 2013;58(5):1632–1643.
   PubMed Web of Science ®Google Scholar
• Miller CO, Yang X, Lu K, et al. Ketohexokinase knockout mice, a model for essential fructosuria, exhibit altered fructose metabolism and are protected from diet-induced metabolic defects. Am J Physiol Endocrinol Metab. 2018;315(3):E386–E393.
   PubMed Web of Science ®Google Scholar
• Roncal-Jimenez CA, Lanaspa MA, Rivard CJ, et al. Sucrose induces fatty liver and pancreatic inflammation in male breeder rats independent of excess energy intake. Metabolism. 2011;60(9):1259–1270.
   PubMed Web of Science ®Google Scholar
• Lanaspa MA, Ishimoto T, Li N, et al. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat Commun. 2013;4(1):2434.
   PubMedGoogle Scholar
• Monetti M, Levin MC, Watt MJ, et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 2007;6(1):69–78.
   PubMed Web of Science ®Google Scholar
• Sud N, Zhang H, Pan K, et al. Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance. J Nutr Biochem. 2017;43:125–131.
   PubMed Web of Science ®Google Scholar